TrialNature communications2025

Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial.

Vivian Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.